ASpire ASDAS by Incuna Asia Pacific

Por um escritor misterioso
Last updated 23 maio 2024
ASpire ASDAS by Incuna Asia Pacific
The ASpire ASDAS application is an exciting new application designed designed by experts to help patients with Ankylosing Spondylitis (AS) manage and learn more about their condition
The ASpire ASDAS application is an exciting new application designed designed by experts to help patients with Ankylosing Spondylitis (AS) manage and learn more about their condition. Aspire App is multilingual and is available in English, Mandarin, Malay, Tamil and Bahasa language versions. ASpire provides you instant access to a comprehensive list of medical information, exercise videos and assessments to help you manage your AS better. ASpire includes both BASDAI and ASDAS questionnaires to assess the severity of the AS condition. Users can use these to monitor their condition over time and, if paired with a prescription, track any subsequent improvement. ASpire also includes a reminders feature to remind users when to record BASDAI/ASDAS scores, take their treatment, or attend an appointment at their hospital. Regular blood tests (CRP), if required can also be stored in this app.
ASpire ASDAS by Incuna Asia Pacific
MySpA by Barts Health NHS Trust
ASpire ASDAS by Incuna Asia Pacific
Aspire Now Global - Crypto, Equity, Financial Modeling
ASpire ASDAS by Incuna Asia Pacific
Meetings – Pharmaleaders TV
ASpire ASDAS by Incuna Asia Pacific
Aspire Inc, Scientific Instruments
ASpire ASDAS by Incuna Asia Pacific
Aspire Inc. - Manufacturer from Bengaluru, India
ASpire ASDAS by Incuna Asia Pacific
iCommit Australia on the App Store
ASpire ASDAS by Incuna Asia Pacific
Aspire Inc, Scientific Instruments
ASpire ASDAS by Incuna Asia Pacific
ASpire ASDAS by Incuna Asia Pacific
ASpire ASDAS by Incuna Asia Pacific
QBE EO Guidelines.pdf
ASpire ASDAS by Incuna Asia Pacific
Aspire Inc. - Manufacturer from Bengaluru, India
ASpire ASDAS by Incuna Asia Pacific
Home - Center for Global Best Practices

© 2014-2024 praharacademy.in. All rights reserved.